Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment

Brain Research

Volumn 839, Issue 2, 1999, Pages 253-262

  Kim, Donghou ^a,b   Su, Joseph ^a   Cotman, Carl W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Dystrophic neurite; Neurofibrillary tangle; Okadaic acid; Tau phosphorylation

Indexed keywords

OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TAU PROTEIN;

ACIDIFICATION; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; DENDRITE; DYSTROPHY; IMMUNOREACTIVITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; AXONS; CELL DEATH; CELL SIZE; CELLS, CULTURED; DENDRITES; ENZYME INHIBITORS; FETUS; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MICROTUBULE-ASSOCIATED PROTEINS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; OKADAIC ACID; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 0033612919     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01724-2     Document Type: Article

References (74)

1. Alonso A.d.C., Zaidi T., Grundke-Iqbal I., Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5562-5566.
2. Alonso A.d.C., Grundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2:1996;783-787.
3. Arendt T., Holzer M., Fruth R., Bruckner M.K., Gartner U. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience. 69:1995;691-698.
4. Arendt T., Holzer M., Fruth R., Bruckner M.K., Gartner U. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol. Aging. 19:1998;3-13.
5. Arias C., Sharma N., Davies P., Shafit-Zagardo B. Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. J. Neurochem. 61:1993;673-682.
6. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
7. Ashford J.W., Soultanian N.S., Zhang S.-X., Geddes J.W. Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J. Neuropathol. Exp. Neurol. 57:1998;972-978.
8. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H.M. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477:1989;90-99.
9. Bancher C., Grunke-Iqbal I., Iqbal K., Fried V.A., Smith H.T., Wisniewski H.M. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer's disease. Brain Res. 539:1991;11-18.
10. Braak H., Braak E. Neuropathpological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
11. Braak E., Braak H., Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87:1994;554-567.
12. Brion J.-P., Couck A.-M., Bruce M., Anderton B., Flament-Durand J. Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease. Brain Res. 539:1991;143-150.
13. Buell S.J., Coleman P.D. Dendritic growth in the aged human brain and failure of growth in senile dementia. Science. 206:1979;854-856.
14. Burack M.A., Halpain S. Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons. Neuroscience. 72:1996;167-184.
15. Caillet-Boudin M.L., Delacourte A. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells. NeuroReport. 8:1996;307-310.
16. Cummings B.J., Pike C.J., Shankle R., Cotman C.W. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging. 17:1996;921-933.
17. Davis D.R., Brion J.-P., Couck A.-M., Gallo J.-M., Hanger D.P., Ladhani K., Lewis C., Miller C.C.J., Rupniak T., Smith C., Anderton B.H. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem. J. 309:1995;941-949.
18. Delacourte A., David J.P., Sergent N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Menza D. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52:1999;1158-1165.
19. Drewes G., Mandelkow E.-M., Baumann K., Goris J., Merlevede W., Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 336:1993;425-432.
20. Dupont-Wallois L., Sautiere P.E., Cocquerelle C., Bailleul B., Delacourte A., Caillet-Boudin M.L. Shift from fetal type to Alzheimer-type phosphorylated tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 357:1995;197-201.
21. Favre B., Turowski P., Hemmings B.A. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J. Biol. Chem. 272:1997;13856-13863.
22. Fleming L.M., Johnson G.V.W. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem. J. 309:1995;41-47.
23. Flood D.G. Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease: II. Subiculum. Brain Res. 540:1991;83-95.
24. Furiya Y., Sahara N., Mori H. Okadaic acid enhances abnormal phosphorylation on tau proteins. Neurosci. Lett. 156:1993;67-69.
25. Garver T.D., Harris K.A., Lehman R.A.W., Lee V.M.-Y., Trojanowski J.Q., Billingsley M.L. Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J. Neurochem. 63:1994;2279-2287.
26. Goedert M., Jakes R., Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189:1995;167-170.
27. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillar tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24.
28. Gong C.-X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer's disease brain. J. Neurochem. 61:1993;921-927.
29. Gong C.-X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience. 61:1994;765-772.
30. Gong C.-X., Grundke-Iqbal I., Damuni Z., Iqbal K. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett. 341:1994;94-98.
31. Gong C.-X., Shaikh S., Wang J.-Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer's disease brain. J. Neurochem. 65:1995;732-738.
32. Hanks S.D., Flood D.G. Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease: I. CA1 of hippocampus. Brain Res. 540:1991;63-82.
33. Ho D.T., Shyan H., Murphy T.H. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J. Neurochem. 68:1997;106-111.
34. P.R. Hof, J.H. Morrison, The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions, Alzheimer's Disease, Raven, New York, 1994, pp. 197-229.
35. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144.
36. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Aβ deposition is associated with neuronal changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
37. Kopke E., Tung Y.-C., Shaikh S., Alonso A.d.C., Iqbal K., Grundke-Iqbal I. Microtubule-associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J. Biol. Chem. 268:1993;24374-24384.
38. 3H ] cantharidin binding site in relation to cytotoxicity J. Pharmacol. Exp. Ther. 280:1997;1152-1158.
39. Lee V.M.-Y., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 251:1991;675-678.
40. Lichtenberg-Kraag B., Mandelkow E.-M., Biernat J., Steiner B., Schroter C., Gustke N., Meyer H.E., Mandelkow E. Phosphorylation dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl. Acad. Sci. 89:1992;5384-5388.
41. Litersky J.M., Johnson G.V.W. Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. J. Neurochem. 65:1995;903-911.
42. Lovestone S., Reynolds C.H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative process. Neuroscience. 78:1997;309-324.
43. Malchiodi-Albedi F., Petrucci T.C., Picconi B., Iosi F., Falchi M. Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons. J. Neurosci. Res. 48:1997;425-438.
44. Masliah E., Honer W.G., Mallory M., Voigt M., Kushner P., Hansen L., Terry R. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol. 87:1994;135-142.
45. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 15:1996;5795-5811.
46. Matsuo E.S., Shin R.-W., Billingsley M.L., Van deVoorde A., O'Connor M., Trojanowski J.Q., Lee V.M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
47. Mawal-Dewan M., Henley J., Van deVoorde A., Trojanowski J.Q., Lee V.M.-Y. Phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269:1994;30981-30987.
48. McKee A.C., Kowall N.W., Kosik K.S. Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann. Neurol. 26:1989;652-659.
49. McKee A.C., Kosik K.S., Kowall N.W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30:1991;156-165.
50. Mercken M., Grynspan F., Nixon R.A. Differential sensitivity to proteolysis by calpain of adult human tau, fetal tau and PHF-tau. FEBS Lett. 368:1995;10-14.
51. Merrick S.E., Trojanowski J.Q., Lee V.M.-Y. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons (NT2N cells). J. Neurosci. 17:1997;5726-5737.
52. 205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J. Biol. Chem. 271:1996;5589-5594.
53. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., Ihara Y. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270:1995;823-829.
54. Neve R.L., Robakis N.K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21:1998;15-19.
55. Nukina N., Kosik K.S., Selkoe D.J. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to cross reaction with tau protein. Proc. Natl. Acad. Sci. 84:1987;3415-3419.
56. Perry G., Kawai M., Tabaton M., Onorato M., Mulvihill P., Richey P., Morandi A., Connolly J.A., Gambetti P. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J. Neurosci. 11:1991;1748-1755.
57. Probst A., Langui D., Ipsen S., Robakis N., Ulrich J. Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol. 83:1991;21-29.
58. Roberts G.W., Nash M., Ince P.G., Royston M.C., Gentleman S.M. On the origin of Alzheimer's disease: a hypothesis. NeuroReport. 4:1993;7-9.
59. Saito T., Ishiguro K., Uchida T., Miyamoto E., Kishimoto T., Hisanaga S.-I. In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEBS Lett. 376:1995;238-242.
60. Saitoh Y., Yamamoto H., Ushio Y., Miyamoto E. Characterization of polyclonal antibodies to brain protein phosphatase 2A and immunohistochemical localization of the enzyme in rat brain. Brain Res. 489:1989;291-301.
61. Schlaepfer W.W. Neurofilament: structure, metabolism and implications in disease. J. Neuropathol. Exp. Neurol. 46:1987;117-129.
62. Sim A.T.R., Ratcliffe E., Mumby M.C., Villa-Moruzzi E., Rostas J.A.P. Differential activities of protein phosphatase types 1 and 2A in cytosolic and particulate fractions from rat forebrain. J. Neurochem. 62:1994;1552-1559.
63. Strack S., Zaucha J.A., Ebner F.F., Colbran R.J., Wadzinski B.E. Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by β subunits. J. Comp. Neurol. 392:1998;515-527.
64. Su J.H., Cummings B.J., Cotman C.W. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. NeuroReport. 5:1994;2358-2362.
65. Su J.H., Cummings B.J., Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease: I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 739:1996;79-87.
66. Su J.H., Cummings B.J., Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease: II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol. 96:1998;463-471.
67. T. Tanaka, J. Zhong, K. Iqbal, E. Trenkner, I. Grunke-Iqbal, The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatase, FEBS Lett., 1998, 248-254.
68. R.D. Terry, E. Masliah, L.A. Hansen, Structural basis of the cognitive alterations in Alzheimer's disease, Alzheimer's disease, Raven, New York, 1994, pp. 179-196.
69. Vandermeeren M., Lubke U., Six J., Cras P. The phosphatase inhibitor okadaic acid induces a phosphorylated paired helical filament tau epitope in human LA-N-5 neuroblastoma cells. Neurosci. Lett. 153:1993;57-60.
70. Vickers J.C., Chin D., Edwards A.-M., Sampson V., Harper C., Morrison J. Dystrophic neurite formation associated with age-related β-amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology. Exp. Neurol. 141:1996;1-11.
71. Vincent I., Rosado M., Kim E., Davies P. Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau. J. Neurochem. 62:1994;715-723.
72. Wang J.-Z., Gong C.-X., Zaidi T., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270:1995;4854-4860.
73. Yamamoto H., Hasegawa M., Ono T., Tashima K., Ihara Y., Miyamoto E. Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. J. Biochem. 118:1995;1224-1231.
74. Yang L.-S., Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233:1995;9-17.